Table 2.

Hematopoietic Stem Cell Numbers at 20 Weeks After Completion of a Six-Cycle Administration of Cytotoxic Agents

Treatment CAFC-28/HL (95% CI) P Value*,CAFC-35/HL (95% CI) P Value*,RU/HL PValue*
Saline  949 (732-1,229)  —  674 (500-908) —  438 ± 90 (12)  —  
VP-16 + cisplatinum NA  NA  426 ± 76 (6)  .84 
Cyclophosphamide  2,805 (1,916-4,106)  <.05 362 (199-660)  NS  610 ± 121 (14)  .43 
Carboplatinum  487 (362-656)  <.05  290 (188-285) <.05  244 ± 79 (10)  .12  
Chlorambucil 1,631 (1,273-2,090)  <.05  371 (278-496)  <.05 135 ± 12 (6)  <.01  
BCNU  1,470 (1,001-2,158) NS  222 (134-368)  <.01  122 ± 13 (19)  <.01 
TBI  582 (450-753)  NS  298 (173-512)  NS 31 ± 8 (8)  <.01 
Treatment CAFC-28/HL (95% CI) P Value*,CAFC-35/HL (95% CI) P Value*,RU/HL PValue*
Saline  949 (732-1,229)  —  674 (500-908) —  438 ± 90 (12)  —  
VP-16 + cisplatinum NA  NA  426 ± 76 (6)  .84 
Cyclophosphamide  2,805 (1,916-4,106)  <.05 362 (199-660)  NS  610 ± 121 (14)  .43 
Carboplatinum  487 (362-656)  <.05  290 (188-285) <.05  244 ± 79 (10)  .12  
Chlorambucil 1,631 (1,273-2,090)  <.05  371 (278-496)  <.05 135 ± 12 (6)  <.01  
BCNU  1,470 (1,001-2,158) NS  222 (134-368)  <.01  122 ± 13 (19)  <.01 
TBI  582 (450-753)  NS  298 (173-512)  NS 31 ± 8 (8)  <.01 

CAFC frequencies were determined from pooled marrow from 3 to 5 mice per experiment, the average frequency was calculated from 1 to 3 experiments with 95% confidence intervals (CI) (given in parentheses). RU/HL was calculated from 6 to 19 recipients (n given in parentheses) that had received marrow pooled from 3 to 5 treated mice; 1 to 3 separate competitive repopulation assays were performed (see Materials and Methods for details).

Abbreviations: NA, not available; NS, not significant.

*

P values are for comparison with saline.

P values for CAFC-28/35 are shown as <.05 (.01 < P < .05), <.01 (.001 < P < .01) or as P < .001.

or Create an Account

Close Modal
Close Modal